Chairpersons’ introduction (part 1)
H.-P. Schlemmer 点击次数：4626
Chairpersons’ introduction (part 2)
J.J. Fütterer 点击次数：4492
Imaging strategies in renal tumours---Chairperson’s introduction
C. Nicolau 点击次数：4863
B. No we don’t!
H. Hricak 点击次数：4910
Is it possible to reduce the number of false positive cases of PI-RADS v.2 classification? Role of quantitative analysis of DCE-MRI in prostate lesions’ characterisation
G. Cristel 点击次数：2122
Image-guided focal treatment using irreversible electroporation (IRE)
F. Collettini 点击次数：2098
Diffusion weighted magnetic resonance imaging in assessment of parenchymal damage in chronic kidney disease
K. Sulkowska 点击次数：2004
B. Prostate
G.M. Villeirs 点击次数：2035
A. Renal and adrenal imaging
N. Grenier 点击次数：2213
C. Prostate imaging
H.C. Thoeny 点击次数：2206
A. Yes we do!
G.M. Villeirs 点击次数：1989
A. Adrenals
L.E. Derchi 点击次数：2032
PI-RADS version 2-based assessment of prostate in patients with borderline-elevated prostate-specific antigen levels: a prospective study
A. Yadav 点击次数：1985
Imaging of prostate cancer: how accurately can prostate cancer be localised?
C. Allen 点击次数：1908
How to prevent patients with a false-positive overall score of PI-RADS 4
T. Ullrich 点击次数：2108
A. Imaging methods, CT and MRI: the best out of two
M.A. Cova 点击次数：2060
